(MENAFN- market Press Release) December 10, 2023 10:35 pm - Industrial property at 3816 DeSoto Blvd. will house manufacturer AlloCyte and 34 Lives, PBC, a two-year old startup that prepares kidneys for transplantation
AlloCyte, LLC, has purchased a 24,560-square-foot, two-story industrial property at 3816 DeSoto Blvd. in northern Pinellas County's Palm Harbor for $4.2 million. The purchase will bring two life sciences companies to the Tampa Bay area – AlloCyte, which plans to be a worldwide manufacturer of the liquids that preserve organs for transplantation, and 34 Lives, PBC, which rescues unused kidneys for transplantation.
AlloCyte is currently moving into the Palm Harbor property's first floor. 34 Lives will move into the second floor when the current tenant, Integer, fully vacates to relocate to another location in April.
Heidi Tuttle-Beisner, broker-owner at Commercial Asset Partners (CAP) Realty, represented the seller, P&B Partnership, in the real estate transaction. The selling entity is affiliated with Thomas Osypka, former owner of medical device manufacturer Oscor, which was headquartered at the property for 34 years before being purchased by Integer in 2021. Jessica Gould of Realty Trust Group represented the buyer.
“We've experienced a significant increase of interest in moving to this area from medical users, ranging from R&D to manufacturing,” Tuttle-Beisner said.“The area's business-friendly atmosphere, excellent quality of life and significant medical initiatives, such as the 775-acre Moffitt Cancer Center project and the expansion of Tampa General Hospital, consistently draw life sciences companies. These companies recognize the appeal of Pinellas and Pasco counties, the broader Tampa Bay area and Florida as a whole.”
34 Lives works to develop innovative technology and services that result in the rescue of thousands of unused kidneys each year, saving lives that would otherwise be lost on the transplantation waitlist. Because of a worldwide shortage in transplant preservation solutions that began during the COVID-19 pandemic, the 34 Lives leadership and investors determined it in their best interest to control their own supply chain and launched AlloCyte last year to produce the organ preservation liquids that 34 Lives – and all other transplant organizations – need.
“The property in Palm Harbor was a good fit for us because the first-floor manufacturing capabilities for AlloCyte were exactly what we needed, as were the 'clean rooms' upstairs for 34 Lives, which essentially are built like operating rooms, with certain air filtration and other requirements for sanitation,” Chris Jaynes, CEO of 34 Lives, said.“This is an ideal location for 34 Lives because of the number of transplant hospitals in Florida, including The Miami Transplant Institute, the nation's largest kidney transplant facility.
Jaynes said AlloCyte plans to hire 25 to 30 people to fill manufacturing positions in the next year. In addition, he expects 34 Lives will hire 25 to 30 people with medical and surgical expertise.
“RTG is honored to support Allocyte in the opening of their Tampa-based bio-manufacturing facility,” said Gould.“Their presence will fill a gap in the Central Florida healthcare ecosystem and make a life-saving difference to transplant patients and families nationwide.”
The Osypka family started Oscor in the property at 3816 DeSoto Blvd., which they constructed 34 years ago. They – and Integer, after Oscor sold to that corporation – have been the building's only occupant.
About Commercial Asset Partners Realty: One of the top mid-sized commercial real estate companies in the Tampa Bay area, CAP Realty handles leasing and sales of retail, office and industrial properties, along with helping clients with real estate investment sales and land transactions. Based in New Port Richey, Fla., Broker-Owner Heidi Tuttle-Beisner and her team have built a company that has the experience and resources to handle a wide range of assignments, while offering a high level of personal service for each client. For more information, see the company's website at
MENAFN11122023003520003262ID1107570196
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.